| Document And Entity Information | Jun. 25, 2024 |
| Document Information [Line Items] | |
| Entity, Registrant Name | DIAMEDICA THERAPEUTICS INC. |
| Document, Type | 8-K |
| Document, Period End Date | Jun. 25, 2024 |
| Entity, Incorporation, State or Country Code | A1 |
| Entity, File Number | 001-36291 |
| Entity, Address, Address Line One | 301 Carlson Parkway |
| Entity, Address, Address Line Two | Suite 210 |
| Entity, Address, City or Town | Minneapolis |
| Entity, Address, State or Province | MN |
| Entity, Address, Postal Zip Code | 55305 |
| City Area Code | 763 |
| Local Phone Number | 496-5454 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Voting common shares, no par value per share |
| Trading Symbol | DMAC |
| Security Exchange Name | NASDAQ |
| Entity, Emerging Growth Company | false |
| Amendment Flag | false |
| Entity, Central Index Key | 0001401040 |
